» Articles » PMID: 34524433

Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth

Abstract

Importance: Preterm birth remains a leading cause of perinatal mortality and lifelong morbidity worldwide. The cause of most preterm births is unknown, although several infectious processes have been implicated.

Objective: To assess whether human papillomavirus (HPV) infection, a frequent infection among women of childbearing age, is associated with preterm birth.

Design, Setting, And Participants: The prospective HERITAGE cohort study was conducted at 3 academic hospitals in Montreal, Québec, Canada, among 899 pregnant women recruited between November 8, 2010, and October 16, 2016. Follow-up was completed on June 15, 2017. Statistical analysis was conducted from February 6, 2020, to January 21, 2021.

Exposures: Vaginal HPV DNA detection in the first and third trimesters of pregnancy and placental HPV infection.

Main Outcomes And Measures: The main outcome was preterm birth (defined as a live birth or stillbirth between 20 weeks and 0 days and 36 weeks and 6 days of gestation). The association between HPV DNA detection and preterm birth was measured using logistic regression. Odds ratios (ORs) and 95% CIs were adjusted by inverse probability of treatment weights of the propensity score.

Results: The study included 899 women (mean [SD] age, 31.3 [4.6] years [range, 19-47 years]) with singleton pregnancies. A total of 378 women (42.0%) had HPV DNA detected in vaginal samples collected during the first trimester, and it was detected in 91 of 819 placentas (11.1%) at delivery. Fifty-five participants experienced preterm birth (38 spontaneous and 17 medically indicated). Persistent vaginal HPV-16/18 detection was significantly associated with all preterm births (adjusted OR [aOR], 3.72; 95% CI, 1.47-9.39) and spontaneous preterm births (aOR, 3.32; 95% CI, 1.13-9.80), as was placental HPV infection (all preterm births: aOR, 2.53; 95% CI, 1.06-6.03; spontaneous preterm births: aOR, 2.92; 95% CI, 1.09-7.81). Results were similar when restricting the analysis to participants without a history of cervical intraepithelial neoplasia treatment.

Conclusions And Relevance: The study's results suggest that persistent HPV-16/18 infection is associated with an increased risk of preterm birth, independent of cervical treatment. Future studies should investigate the association of HPV vaccination and vaccination programs with the risk of preterm birth.

Citing Articles

Prevalence of HPV genotypes and their association with reproductive tract inflammation and pregnancy outcomes among reproductive-age women in Ningbo, China: a retrospective cohort study (2016-2020).

He N, Song X, Song Q, Ding H BMC Infect Dis. 2025; 25(1):263.

PMID: 39994622 PMC: 11853790. DOI: 10.1186/s12879-025-10522-4.


Exploring the Role of Lower Genital Tract Microbiota and Cervical-Endometrial Immune Metabolome in Unknown Genesis of Recurrent Pregnancy Loss.

Mikhalev S, Kurtser M, Radzinsky V, Orazov M, Beeraka N, Mikhaleva L Int J Mol Sci. 2025; 26(3).

PMID: 39941094 PMC: 11818274. DOI: 10.3390/ijms26031326.


Viral Load of Human Papillomavirus (HPV) During Pregnancy and Its Association With HPV Vertical Transmission.

Benard E, Carceller A, Mayrand M, Lacroix J, Niyibizi J, Laporte L J Med Virol. 2025; 97(2):e70221.

PMID: 39912394 PMC: 11800320. DOI: 10.1002/jmv.70221.


Human papillomavirus infections during pregnancy and adverse pregnancy outcomes: a Scandinavian prospective mother-child cohort study.

Vaernesbranden M, Staff A, Wiik J, Sjoborg K, Rueegg C, Sugulle M BMC Pregnancy Childbirth. 2024; 24(1):764.

PMID: 39563227 PMC: 11575420. DOI: 10.1186/s12884-024-06958-2.


Frequency and Risk Factors Associated with Prematurity: A Cohort Study in a Neonatal Intensive Care Unit.

Barreto M, Manso M, Barreto R, Barreto R, Vasconcelos L, Silva C J Clin Med. 2024; 13(15).

PMID: 39124704 PMC: 11313331. DOI: 10.3390/jcm13154437.


References
1.
Cho G, Min K, Hong H, Kim S, Hong J, Lee J . High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth. 2013; 13:173. PMC: 3846597. DOI: 10.1186/1471-2393-13-173. View

2.
Mosbah A, Barakat R, Nabiel Y, Barakat G . High-risk and low-risk human papilloma virus in association to spontaneous preterm labor: a case-control study in a tertiary center, Egypt. J Matern Fetal Neonatal Med. 2017; 31(6):720-725. DOI: 10.1080/14767058.2017.1297403. View

3.
Schmeink C, Melchers W, Hendriks J, Quint W, Massuger L, Bekkers R . Human papillomavirus detection in pregnant women: a prospective matched cohort study. J Womens Health (Larchmt). 2012; 21(12):1295-301. DOI: 10.1089/jwh.2012.3502. View

4.
Henneberg A, Patton W, Jacobson J, Chan P . Human papilloma virus DNA exposure and embryo survival is stage-specific. J Assist Reprod Genet. 2006; 23(6):255-9. PMC: 3506371. DOI: 10.1007/s10815-006-9030-8. View

5.
Niyibizi J, Zanre N, Mayrand M, Trottier H . Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis. J Infect Dis. 2020; 221(12):1925-1937. PMC: 7289546. DOI: 10.1093/infdis/jiaa054. View